TOP STORIES

• REGULATORY Japan Launches Public-Private Council to Create Innovation Ecosystem
  June 27, 2025

• REGULATORY DPP’s Tamura Renews Call to Scrap Off-Year Drug Price Cuts, Urges Protection of On-Patent Prices
  June 26, 2025

• REGULATORY Japan Begins FY2026 Drug Pricing Reform Talks; Responses to Inflation, High-Cost Therapies on Agenda
  June 26, 2025

• REGULATORY Japan Approves MSD’s Airwin/Welireg, J&J Bispecific, and More
  June 25, 2025

• BUSINESS Aculys Moves Toward First Launch as It Tackles Japan’s Drug Lag/Loss
  June 24, 2025

• COMMENTARY Honebuto 2025 Approved - The Real Battle for Pharma Lies Ahead
  June 23, 2025

• ORGANIZATION JGA Targets FY2027 for Resolving Drug Shortages, Two Years Ahead of Forecast
  June 20, 2025

• BUSINESS Will Moderna See Multiple Japan Filings in the Coming Years? 5 Late-Stage Assets in Pipeline
  June 19, 2025

• BUSINESS Taking on Solid Tumors - 6: Pfizer Japan Sees Rosy Uptake with Elrexfio, Mulling Bringing Bispecific Assets for Solid Cancers Too
  June 18, 2025

• ORGANIZATION JMA’s Upper House Candidate Says Scraping Drug Prices to Pool Resources No Longer Holds
  June 17, 2025

• REGULATORY Japan OKs Honebuto Paper with Softened Phrasing on CEA, Sign of Change to Social Security Budgeting
  June 16, 2025

• ORGANIZATION Policy Veterans’ Group Opposes Expansion of CEA Price Adjustments
  June 13, 2025

• BUSINESS AbbVie Japan Looks to Double Sales by 2029 with Rinvoq and Skyrizi as Engines
  June 12, 2025

• BUSINESS Prashant Nikam to Take Over Helm of MSD Japan
  June 12, 2025

• BUSINESS Taking on Solid Tumors - 5: Genmab Pursuing Unique T-Cell Engager Program for Lung Cancer
  June 11, 2025

• BUSINESS Taking on Solid Tumors - 4: With 2 Late-Stage Assets in Wings, Will AstraZeneca Reshape CP Inhibitor Landscape?
  June 10, 2025

• REGULATORY LDP Lawmakers Push Back on Honebuto Draft over CEA, Social Security Budgeting
  June 10, 2025

• REGULATORY Honebuto Draft Urges Promotion of Drug Innovation, but Spells Out CEA Expansion Too
  June 9, 2025

• BUSINESS Takeda Rolls Out AI Tool to Guide “Next Best Action” in Sales
  June 6, 2025

• ORGANIZATION New FPMAJ Chair Pushes Category-Based Drug Pricing to Ensure Innovation, Stable Supply
  June 5, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• …
• Next ›
• 最終 »